The device failures could lead to increased or decreased values of CO2, which could be fatal, according to a U.S. Food and Drug Administration news release. Additionally, physicians may make clinical decisions based off incorrect displayed values, potentially causing permanent impairment or life-threatening changes.
Currently there have been no reports of injury or death associated with the recalled device, according to the news release.
More articles on recalls:
American Health Packaging recalls oxcarbazepine, ibuprofren for mislabeled packages
Baxter initiates worldwide saline solution recall
Hospira recalls Encore Infusion pumps
